Jeff Stibelman’s journey with lung cancer began unexpectedly. After successfully battling a cancerous mass in his neck, Jeff faced another shocking diagnosis in 2021 – Stage 4 lung cancer with metastases to his bones, ribs, clavicle, and brain.
From Garment Industry to Lung Cancer Research Advocate: Jeff Stibelman’s Story
What started as a “little cough” led to a chest X-ray that revealed a large lesion in his lower right lobe. More concerning was learning this nodule had been present, but unreported, since 2017. Rather than dwelling on this oversight, Jeff channeled his energy into becoming knowledgeable about lung cancer research, testing, and treatment options.
“I could (and should) be enraged that this information was withheld. Instead I opted to take that energy and concentrate on learning everything about everything: research, testing, biomarker testing,” Jeff explains.
This dedication to understanding his disease led to discovering he carried the EGFR+ mutation, making him eligible for targeted therapy. While doctors initially suggested this might extend his life by 6-12 months, Jeff embraced the opportunity without hesitation.
Today, Jeff is a passionate advocate for lung cancer research and awareness. His mission is clear:
“I don’t want my story to be about me, Jeff Stibelman. I want my story to be about focusing on the disease and the cure. Being there for people helps not only the patient, but me. If I can save a life, I am doing my job.”
Jeff encourages others to be proactive about their health – to trust their instincts, ask questions, and demand answers. His story exemplifies how research and biomarker testing can transform a patient’s journey and why continued advocacy for lung cancer research is crucial.
